Diabetes Research Centers (P30)
The summary for the Diabetes Research Centers (P30) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diabetes Research Centers (P30): This Request for Applications (RFA) solicits new and competing continuation applications for Diabetes Endocrinology Research Centers (DERCs) and Diabetes Research and Training Centers (DRTCs). Both types of centers are designed to support and enhance the national research effort in diabetes and related endocrine and metabolic diseases.
Federal Grant Title: | Diabetes Research Centers (P30) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DK-06-012 |
Type of Funding: | Grant |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Endocrinology and Metabolism Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Jul 27, 2006 |
Posted Date: | Apr 07, 2006 |
Creation Date: | Apr 18, 2006 |
Archive Date: | Aug 26, 2006 |
Total Program Funding: | $5,500,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 3 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses Independent school districts City or township governments Private institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities County governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...
- • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...
- • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...
- • Diabetes Research Centers (P30 Clinical Trial Optional)
- • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...